Target intelligence / Profile preview

Agglutinin-like sequence 3 (Als3) (Als3)

Target
Als3
Molecular classification
Receptor, Adhesin, Invasin, Cell surface glycoprotein, Other
01

Overview

Agglutinin-like sequence 3 (Als3) is a multifunctional cell surface glycoprotein expressed by the opportunistic fungal pathogen Candida albicans, primarily during its hyphal phase [UniProt P46590]. It serves as a critical adhesin and invasin, mediating the attachment of the fungus to host epithelial and endothelial cells and facilitating host cell entry by binding to E-cadherin and N-cadherin [PubMed: 21937687]. Furthermore, Als3 acts as a ferritin receptor, enabling the fungus to acquire essential iron from the host environment, which is vital for its growth and virulence [PubMed: 18948420]. Due to its high expression during infection and its essential role in pathogenesis, Als3 is the primary target for the NDV-3 and NDV-3A vaccines [PubMed: 24106299]. These vaccines leverage the host adaptive immune system to generate protective Th1 and Th17 cellular responses and inhibitory antibodies that prevent fungal colonization, biofilm formation, and dissemination [PubMed: 29688287].

Other names
Als3pAgglutinin-like protein 3Candida albicans Als3NDV-3 antigenFerritin receptor
02

Mechanism of action

Induction of host adaptive immunity through the stimulation of Th1 and Th17 cell-mediated responses and the production of neutralizing antibodies that block fungal adhesion and invasion.

03

Biological functions

Immune responseCell adhesionHost cell invasionIron acquisitionBiofilm formationOther
04

Disease associations

InfectionOther
05

Safety considerations

Injection site reactions (erythema, swelling, pain)Systemic symptoms (fatigue, headache, myalgia)Potential for immune-mediated inflammatory responses
06

Interacting drugs

NDV-3

1 more in the full profile.

07

Biomarkers

Anti-Als3 IgG antibody titersInterferon-gamma (IFN-γ) levelsInterleukin-17 (IL-17) levelsT-cell proliferation assays

Beyond the preview

Go deeper on Agglutinin-like sequence 3 (Als3) (Als3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agglutinin-like sequence 3 (Als3) (Als3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call